IP Library Granted Patent US 12,565,644
Granted Patent B2
US 12,565,644 · App. 17/633,408 · Granted Mar 3, 2026

Nucleic acid purification chemistry

Inventor: Max Haesendonckx (Mechelen, BE)
Assignee: Biocartis NV
C12N15/1006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,565,644
App. No.
17/633,408
Granted
Mar 3, 2026
Kind
B2
Abstract

The present invention generally relates to the field of nucleic acid isolation on silica solid support. In particular, a novel silica-solid support nucleic acid binding buffer chemistry is hereby disclosed, which is based on the use of a small quaternary organic compounds, e.g. tetramethylammonium chloride (TMAC), at acidic conditions. This novel nucleic acid purification chemistry purifies not only RNA but also DNA and has the potential for being implementable in a wide variety of commercial kits ranging from the spin columns to integrated Lab-On-A-Chip (LOC) devices such as disposable cartridges that make use of a solid-phase extraction technology. Furthermore, the present methods may be performed using relatively small volumes of binding buffer and consequently in such integrated or closed molecular diagnostic devices, they have the potential of allowing increased volumes of sample input, which for liquid biopsy samples such as plasma or urine, can enhance the chances of detecting rare nucleic acid targets.

Claims (20)

1 . A double-stranded DNA (dsDNA) extraction method comprising contacting a liquid biopsy sample with a silica solid support at pH value between 3 and 6 and in the presence of a salt consisting of:

a small quaternary organic compound, defined as a quaternary compound consisting of a central positively charged atom with four organic substituents (R1, R2, R3, and R4), wherein the number of carbon atoms in each organic substituent (R1, R2, R3, and R4) does not exceed 2; and

a bromide or a chloride anion to extract dsDNA of 10 to 300 base pairs;

wherein the central positively charged atom of the small quaternary organic compound is nitrogen, and wherein the concentration of the small quaternary organic compound is 0.1 M-2 M.

2 . The method according to claim 1 , wherein the anion is chloride.

3 . The method according to claim 2 , wherein the small quaternary organic compound is tetramethylammonium chloride (TMAC).

4 . The method according to claim 1 , wherein the concentration of the small quaternary organic compound is 0.5 M-1.8 M.

5 . The method according to claim 1 , wherein the pH value is 4-5.8.

6 . The method according to claim 1 , wherein the contacting with the silica solid support is preceded by a protease treatment.

7 . The method according to claim 1 , wherein the liquid biopsy sample is selected from plasma, serum, whole blood, or urine.

8 . The method according to claim 1 , wherein the dsDNA is cell free dsDNA.

9 . The method according to claim 1 , wherein the dsDNA is circulating tumor dsDNA.

10 . The method according to claim 1 , wherein the contacting is further in the presence of a detergent.

11 . The method according claim 10 , wherein the detergent is a quaternary ammonium compound detergent.

12 . The method according claim 11 , wherein the quaternary ammonium compound detergent is cetyltrimethylammonium bromide (CTAB).

13 . The method according to claim 1 , wherein the method is performed using a cartridge.

14 . The method according to claim 1 , wherein the concentration of the small quaternary organic compound is about 1.2 M.

15 . The method according to claim 1 , wherein the pH value is 4.2-5.6.

16 . The method according to claim 1 , wherein the pH value is 4.4-5.4.

17 . The method according to claim 1 , wherein the pH value is about 5.

Assignments (4)
SECURITY INTEREST Recorded Oct 31, 2023
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 065411/0175 →
SECURITY INTEREST Recorded Nov 4, 2022
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 061657/0976 →
SECURITY INTEREST Recorded Oct 28, 2022
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 061583/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2022
From: HAESENDONCKX, MAX
To: BIOCARTIS NV
Reel/Frame 058925/0503 →
Priority Claims (1)
EP 19190647 · Aug 8, 2019 · regional
Continuity (1)
Related Publication 20230399633A1 · Dec 14, 2023
References Cited (22)
US 2010015A · Fletcher · 1935 [cited by examiner]
US 5610287A · Nikiforov · 1997 [cited by examiner]
US 7932551B2 · Kim et al. · 2011 [cited by applicant]
US 20020103350A1 · Lyles · 2002 [cited by applicant]
US 20050009036A1 · Montesclaros · 2005 [cited by examiner]
EP 389063A2 · 1990 [cited by applicant]
EP 1896180A2 · 2008 [cited by applicant]
EP 1904234A1 · 2008 [cited by applicant]
EP 198351A2 · 2008 [cited by applicant]
EP 2419705A1 · 2012 [cited by applicant]
WO 9515970A1 · 1995 [cited by applicant]
WO 2007004103A1 · 2007 [cited by applicant]
WO 2010015835A1 · 2011 [cited by applicant]
WO 2015165859A1 · 2015 [cited by applicant]
WO 2016073824A1 · 2016 [cited by applicant]
WO 2018156906A1 · 2018 [cited by applicant]
Boom, R. et al. “Rapid and Simple Method for Purification of Nucleic Acids”. Journal of Clinical Microbiology, vol. 28, No. 3, 495-503, (Mar. 1990). [cited by applicant]
Hourfar, M. et al. “High-Throughput Purification of Viral RNA Based on Novel Aqueous Chemistry for Nucleic Acid Isolation”. Clinical Chemistry, 51:7, 1217-1222, (2005). [cited by applicant]
Melzak, K. et al. “Driving Forces for DNA Adsorption to Silica in Perchlorate Solutions”. vol. 181, Issue 2, Aug. 10, 1996, pp. 635-644. [cited by applicant]
J. M. Orosz and J. G. Wetmur. “DNA melting temperatures and renaturation rates in concentrated alkylammonium salt solutions”. Biopolymers, vol. 16, 1183-1199, 1977. [cited by applicant]
Meek et al. “Enzymes adsorbed on an ion exchanger as a post-col. reactor: application to acetylcholine measurement” (1984 J.Chrom. 317: 343-347). [cited by applicant]
Unceta et al. “Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography” (2008 J.Pharm. Bi… [cited by applicant]